Wyeth's Sales Tactics Not Anti-Competitive: Court
A group of pharmaceutical wholesalers has lost an appeal brought against Wyeth-Ayerst Laboratories over claims the drug maker hiked up the price of its hormone medication while keeping its competitor out...To view the full article, register now.
Already a subscriber? Click here to view full article